ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antifungal Drugs for Skin Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-3N18285
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Antifungal Drugs for Skin Market Research Report 2024
BUY CHAPTERS

Global Antifungal Drugs for Skin Market Research Report 2024

Code: QYRE-Auto-3N18285
Report
August 2024
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Harbin Labton Pharmaceutical Co., Ltd.
Jiangsu Chenpai Pharmaceutical Group Co. LTD
Livzon Group Livzon Pharmaceutical Factory
Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
Teyi Pharmaceutical Group Co.,Ltd.
Lunan Beite Pharmaceutical Co., Ltd.
Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
Shanghai Baolong Pharmaceutical Co., Ltd.
Shandong FANGMING Pharmaceutical Group Co., Ltd.
Nanjing Chengong Pharmaceutical Co., Ltd.
Zhejiang East Asia Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co. Ltd.
Pfizer Inc
Wellona Pharma
Aden Healthcare
AS Lifesciences
Amar Healthcare
Advacare Pharma
Shree Ganesh Remedies
Dr. Reddy’s Laboratories
Yunnan Longrun Pharmaceutical Co., Ltd.
Hubei Hengan Fulin Pharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Bioengineering Co., Ltd.
Solisom Healthcare

Antifungal Drugs for Skin Market

Antifungal drugs for skin use refer to drugs used to treat fungal infections of the skin. This type of drug is mainly used to fight fungi that cause skin lesions, such as dermatophytes, yeasts, and molds. Common fungal infections of the skin include tinea pedis (athlete's foot), tinea corporis, tinea cruris, tinea capitis, tinea versicolor (tinea versicolor), etc. Antifungal drugs for skin use can be divided into two categories: topical and oral, and are used according to the type, location, and severity of the infection.
The global Antifungal Drugs for Skin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Antifungal Drugs for Skin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antifungal Drugs for Skin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Antifungal Drugs for Skin include Harbin Labton Pharmaceutical Co., Ltd., Jiangsu Chenpai Pharmaceutical Group Co., Ltd., Livzon Group Livzon Pharmaceutical Factory, Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd., Teyi Pharmaceutical Group Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd., Yunnan Longrun Pharmaceutical Co., Ltd., Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd., Shandong Chenxin Fodu Pharmaceutical Co., Ltd., Shanghai Baolong Pharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antifungal Drugs for Skin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antifungal Drugs for Skin.
The Antifungal Drugs for Skin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Antifungal Drugs for Skin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antifungal Drugs for Skin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antifungal Drugs for Skin Market Report

Report Metric Details
Report Name Antifungal Drugs for Skin Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Harbin Labton Pharmaceutical Co., Ltd., Jiangsu Chenpai Pharmaceutical Group Co., Ltd., Livzon Group Livzon Pharmaceutical Factory, Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd., Teyi Pharmaceutical Group Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd., Yunnan Longrun Pharmaceutical Co., Ltd., Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd., Shandong Chenxin Fodu Pharmaceutical Co., Ltd., Shanghai Baolong Pharmaceutical Co., Ltd., Shandong Fangming Pharmaceutical Group Co., Ltd., Nanjing Chengong Pharmaceutical Co., Ltd., Hubei Hengan Fulin Pharmaceutical Co., Ltd., Zhejiang East Asia Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Qilu Pharmaceutical Co., Ltd., Harbin Pharmaceutical Group Bioengineering Co., Ltd., Pfizer, Wellona Pharma, Aden Healthcare, Solisom Healthcare, AS lifesciences, Amar Healthcare, AdvaCare Pharma, Shree Ganesh Remedies, Dr. Reddy's Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antifungal Drugs for Skin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antifungal Drugs for Skin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Antifungal Drugs for Skin Market report?

Ans: The main players in the Antifungal Drugs for Skin Market are Harbin Labton Pharmaceutical Co., Ltd., Jiangsu Chenpai Pharmaceutical Group Co., Ltd., Livzon Group Livzon Pharmaceutical Factory, Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd., Teyi Pharmaceutical Group Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd., Yunnan Longrun Pharmaceutical Co., Ltd., Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd., Shandong Chenxin Fodu Pharmaceutical Co., Ltd., Shanghai Baolong Pharmaceutical Co., Ltd., Shandong Fangming Pharmaceutical Group Co., Ltd., Nanjing Chengong Pharmaceutical Co., Ltd., Hubei Hengan Fulin Pharmaceutical Co., Ltd., Zhejiang East Asia Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Qilu Pharmaceutical Co., Ltd., Harbin Pharmaceutical Group Bioengineering Co., Ltd., Pfizer, Wellona Pharma, Aden Healthcare, Solisom Healthcare, AS lifesciences, Amar Healthcare, AdvaCare Pharma, Shree Ganesh Remedies, Dr. Reddy's Laboratories

What are the Application segmentation covered in the Antifungal Drugs for Skin Market report?

Ans: The Applications covered in the Antifungal Drugs for Skin Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Antifungal Drugs for Skin Market report?

Ans: The Types covered in the Antifungal Drugs for Skin Market report are Ciprofloxacin, Clotrimazole, Miconazole, Amorolfine, Butenafine, Econazole, Ketoconazole, Terbinafine, Other

Recommended Reports

Antifungal Drug Markets

Topical & Skin Fungal

Gynecological Antifungals

1 Antifungal Drugs for Skin Market Overview
1.1 Product Definition
1.2 Antifungal Drugs for Skin by Type
1.2.1 Global Antifungal Drugs for Skin Market Value Comparison by Type (2024-2030)
1.2.2 Ciprofloxacin
1.2.3 Clotrimazole
1.2.4 Miconazole
1.2.5 Amorolfine
1.2.6 Butenafine
1.2.7 Econazole
1.2.8 Ketoconazole
1.2.9 Terbinafine
1.2.10 Other
1.3 Antifungal Drugs for Skin by Application
1.3.1 Global Antifungal Drugs for Skin Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Antifungal Drugs for Skin Market Size Estimates and Forecasts
1.4.1 Global Antifungal Drugs for Skin Revenue 2019-2030
1.4.2 Global Antifungal Drugs for Skin Sales 2019-2030
1.4.3 Global Antifungal Drugs for Skin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antifungal Drugs for Skin Market Competition by Manufacturers
2.1 Global Antifungal Drugs for Skin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antifungal Drugs for Skin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antifungal Drugs for Skin Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Antifungal Drugs for Skin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antifungal Drugs for Skin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antifungal Drugs for Skin, Product Type & Application
2.7 Global Key Manufacturers of Antifungal Drugs for Skin, Date of Enter into This Industry
2.8 Global Antifungal Drugs for Skin Market Competitive Situation and Trends
2.8.1 Global Antifungal Drugs for Skin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antifungal Drugs for Skin Players Market Share by Revenue
2.8.3 Global Antifungal Drugs for Skin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antifungal Drugs for Skin Market Scenario by Region
3.1 Global Antifungal Drugs for Skin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antifungal Drugs for Skin Sales by Region: 2019-2030
3.2.1 Global Antifungal Drugs for Skin Sales by Region: 2019-2024
3.2.2 Global Antifungal Drugs for Skin Sales by Region: 2025-2030
3.3 Global Antifungal Drugs for Skin Revenue by Region: 2019-2030
3.3.1 Global Antifungal Drugs for Skin Revenue by Region: 2019-2024
3.3.2 Global Antifungal Drugs for Skin Revenue by Region: 2025-2030
3.4 North America Antifungal Drugs for Skin Market Facts & Figures by Country
3.4.1 North America Antifungal Drugs for Skin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antifungal Drugs for Skin Sales by Country (2019-2030)
3.4.3 North America Antifungal Drugs for Skin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antifungal Drugs for Skin Market Facts & Figures by Country
3.5.1 Europe Antifungal Drugs for Skin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antifungal Drugs for Skin Sales by Country (2019-2030)
3.5.3 Europe Antifungal Drugs for Skin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antifungal Drugs for Skin Market Facts & Figures by Region
3.6.1 Asia Pacific Antifungal Drugs for Skin Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antifungal Drugs for Skin Sales by Region (2019-2030)
3.6.3 Asia Pacific Antifungal Drugs for Skin Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antifungal Drugs for Skin Market Facts & Figures by Country
3.7.1 Latin America Antifungal Drugs for Skin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antifungal Drugs for Skin Sales by Country (2019-2030)
3.7.3 Latin America Antifungal Drugs for Skin Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Antifungal Drugs for Skin Market Facts & Figures by Country
3.8.1 Middle East and Africa Antifungal Drugs for Skin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antifungal Drugs for Skin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antifungal Drugs for Skin Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antifungal Drugs for Skin Sales by Type (2019-2030)
4.1.1 Global Antifungal Drugs for Skin Sales by Type (2019-2024)
4.1.2 Global Antifungal Drugs for Skin Sales by Type (2025-2030)
4.1.3 Global Antifungal Drugs for Skin Sales Market Share by Type (2019-2030)
4.2 Global Antifungal Drugs for Skin Revenue by Type (2019-2030)
4.2.1 Global Antifungal Drugs for Skin Revenue by Type (2019-2024)
4.2.2 Global Antifungal Drugs for Skin Revenue by Type (2025-2030)
4.2.3 Global Antifungal Drugs for Skin Revenue Market Share by Type (2019-2030)
4.3 Global Antifungal Drugs for Skin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antifungal Drugs for Skin Sales by Application (2019-2030)
5.1.1 Global Antifungal Drugs for Skin Sales by Application (2019-2024)
5.1.2 Global Antifungal Drugs for Skin Sales by Application (2025-2030)
5.1.3 Global Antifungal Drugs for Skin Sales Market Share by Application (2019-2030)
5.2 Global Antifungal Drugs for Skin Revenue by Application (2019-2030)
5.2.1 Global Antifungal Drugs for Skin Revenue by Application (2019-2024)
5.2.2 Global Antifungal Drugs for Skin Revenue by Application (2025-2030)
5.2.3 Global Antifungal Drugs for Skin Revenue Market Share by Application (2019-2030)
5.3 Global Antifungal Drugs for Skin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Harbin Labton Pharmaceutical Co., Ltd.
6.1.1 Harbin Labton Pharmaceutical Co., Ltd. Company Information
6.1.2 Harbin Labton Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.1.5 Harbin Labton Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Jiangsu Chenpai Pharmaceutical Group Co., Ltd.
6.2.1 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Company Information
6.2.2 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Description and Business Overview
6.2.3 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.2.5 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.3 Livzon Group Livzon Pharmaceutical Factory
6.3.1 Livzon Group Livzon Pharmaceutical Factory Company Information
6.3.2 Livzon Group Livzon Pharmaceutical Factory Description and Business Overview
6.3.3 Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Product Portfolio
6.3.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments/Updates
6.4 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
6.4.1 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Company Information
6.4.2 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.4.5 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Teyi Pharmaceutical Group Co., Ltd.
6.5.1 Teyi Pharmaceutical Group Co., Ltd. Company Information
6.5.2 Teyi Pharmaceutical Group Co., Ltd. Description and Business Overview
6.5.3 Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.5.5 Teyi Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.6 Lunan Beite Pharmaceutical Co., Ltd.
6.6.1 Lunan Beite Pharmaceutical Co., Ltd. Company Information
6.6.2 Lunan Beite Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.6.5 Lunan Beite Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Yunnan Longrun Pharmaceutical Co., Ltd.
6.7.1 Yunnan Longrun Pharmaceutical Co., Ltd. Company Information
6.7.2 Yunnan Longrun Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.7.5 Yunnan Longrun Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
6.8.1 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Company Information
6.8.2 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.8.5 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
6.9.1 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Company Information
6.9.2 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.9.5 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Shanghai Baolong Pharmaceutical Co., Ltd.
6.10.1 Shanghai Baolong Pharmaceutical Co., Ltd. Company Information
6.10.2 Shanghai Baolong Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.10.5 Shanghai Baolong Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Shandong Fangming Pharmaceutical Group Co., Ltd.
6.11.1 Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information
6.11.2 Shandong Fangming Pharmaceutical Group Co., Ltd. Description and Business Overview
6.11.3 Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.11.5 Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.12 Nanjing Chengong Pharmaceutical Co., Ltd.
6.12.1 Nanjing Chengong Pharmaceutical Co., Ltd. Company Information
6.12.2 Nanjing Chengong Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.12.5 Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Hubei Hengan Fulin Pharmaceutical Co., Ltd.
6.13.1 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Company Information
6.13.2 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Description and Business Overview
6.13.3 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.13.5 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Zhejiang East Asia Pharmaceutical Co., Ltd.
6.14.1 Zhejiang East Asia Pharmaceutical Co., Ltd. Company Information
6.14.2 Zhejiang East Asia Pharmaceutical Co., Ltd. Description and Business Overview
6.14.3 Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.14.5 Zhejiang East Asia Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Southwest Pharmaceutical Co., Ltd.
6.15.1 Southwest Pharmaceutical Co., Ltd. Company Information
6.15.2 Southwest Pharmaceutical Co., Ltd. Description and Business Overview
6.15.3 Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.15.5 Southwest Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Qilu Pharmaceutical Co., Ltd.
6.16.1 Qilu Pharmaceutical Co., Ltd. Company Information
6.16.2 Qilu Pharmaceutical Co., Ltd. Description and Business Overview
6.16.3 Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.16.5 Qilu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Harbin Pharmaceutical Group Bioengineering Co., Ltd.
6.17.1 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Company Information
6.17.2 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Description and Business Overview
6.17.3 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Product Portfolio
6.17.5 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Recent Developments/Updates
6.18 Pfizer
6.18.1 Pfizer Company Information
6.18.2 Pfizer Description and Business Overview
6.18.3 Pfizer Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Pfizer Antifungal Drugs for Skin Product Portfolio
6.18.5 Pfizer Recent Developments/Updates
6.19 Wellona Pharma
6.19.1 Wellona Pharma Company Information
6.19.2 Wellona Pharma Description and Business Overview
6.19.3 Wellona Pharma Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Wellona Pharma Antifungal Drugs for Skin Product Portfolio
6.19.5 Wellona Pharma Recent Developments/Updates
6.20 Aden Healthcare
6.20.1 Aden Healthcare Company Information
6.20.2 Aden Healthcare Description and Business Overview
6.20.3 Aden Healthcare Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Aden Healthcare Antifungal Drugs for Skin Product Portfolio
6.20.5 Aden Healthcare Recent Developments/Updates
6.21 Solisom Healthcare
6.21.1 Solisom Healthcare Company Information
6.21.2 Solisom Healthcare Description and Business Overview
6.21.3 Solisom Healthcare Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Solisom Healthcare Antifungal Drugs for Skin Product Portfolio
6.21.5 Solisom Healthcare Recent Developments/Updates
6.22 AS lifesciences
6.22.1 AS lifesciences Company Information
6.22.2 AS lifesciences Description and Business Overview
6.22.3 AS lifesciences Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.22.4 AS lifesciences Antifungal Drugs for Skin Product Portfolio
6.22.5 AS lifesciences Recent Developments/Updates
6.23 Amar Healthcare
6.23.1 Amar Healthcare Company Information
6.23.2 Amar Healthcare Description and Business Overview
6.23.3 Amar Healthcare Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Amar Healthcare Antifungal Drugs for Skin Product Portfolio
6.23.5 Amar Healthcare Recent Developments/Updates
6.24 AdvaCare Pharma
6.24.1 AdvaCare Pharma Company Information
6.24.2 AdvaCare Pharma Description and Business Overview
6.24.3 AdvaCare Pharma Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.24.4 AdvaCare Pharma Antifungal Drugs for Skin Product Portfolio
6.24.5 AdvaCare Pharma Recent Developments/Updates
6.25 Shree Ganesh Remedies
6.25.1 Shree Ganesh Remedies Company Information
6.25.2 Shree Ganesh Remedies Description and Business Overview
6.25.3 Shree Ganesh Remedies Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Shree Ganesh Remedies Antifungal Drugs for Skin Product Portfolio
6.25.5 Shree Ganesh Remedies Recent Developments/Updates
6.26 Dr. Reddy's Laboratories
6.26.1 Dr. Reddy's Laboratories Company Information
6.26.2 Dr. Reddy's Laboratories Description and Business Overview
6.26.3 Dr. Reddy's Laboratories Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Dr. Reddy's Laboratories Antifungal Drugs for Skin Product Portfolio
6.26.5 Dr. Reddy's Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antifungal Drugs for Skin Industry Chain Analysis
7.2 Antifungal Drugs for Skin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antifungal Drugs for Skin Production Mode & Process
7.4 Antifungal Drugs for Skin Sales and Marketing
7.4.1 Antifungal Drugs for Skin Sales Channels
7.4.2 Antifungal Drugs for Skin Distributors
7.5 Antifungal Drugs for Skin Customers
8 Antifungal Drugs for Skin Market Dynamics
8.1 Antifungal Drugs for Skin Industry Trends
8.2 Antifungal Drugs for Skin Market Drivers
8.3 Antifungal Drugs for Skin Market Challenges
8.4 Antifungal Drugs for Skin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Harbin Labton Pharmaceutical Co., Ltd.
Jiangsu Chenpai Pharmaceutical Group Co. LTD
Livzon Group Livzon Pharmaceutical Factory
Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
Teyi Pharmaceutical Group Co.,Ltd.
Lunan Beite Pharmaceutical Co., Ltd.
Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
Shanghai Baolong Pharmaceutical Co., Ltd.
Shandong FANGMING Pharmaceutical Group Co., Ltd.
Nanjing Chengong Pharmaceutical Co., Ltd.
Zhejiang East Asia Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co. Ltd.
Pfizer Inc
Wellona Pharma
Aden Healthcare
AS Lifesciences
Amar Healthcare
Advacare Pharma
Shree Ganesh Remedies
Dr. Reddy’s Laboratories
Yunnan Longrun Pharmaceutical Co., Ltd.
Hubei Hengan Fulin Pharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Bioengineering Co., Ltd.
Solisom Healthcare
List of Tables
 Table 1. Global Antifungal Drugs for Skin Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Antifungal Drugs for Skin Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Antifungal Drugs for Skin Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Antifungal Drugs for Skin Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Antifungal Drugs for Skin Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Antifungal Drugs for Skin Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Antifungal Drugs for Skin Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Antifungal Drugs for Skin Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Antifungal Drugs for Skin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antifungal Drugs for Skin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antifungal Drugs for Skin, Product Type & Application
 Table 12. Global Key Manufacturers of Antifungal Drugs for Skin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antifungal Drugs for Skin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal Drugs for Skin as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antifungal Drugs for Skin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Antifungal Drugs for Skin Sales by Region (2019-2024) & (K Units)
 Table 18. Global Antifungal Drugs for Skin Sales Market Share by Region (2019-2024)
 Table 19. Global Antifungal Drugs for Skin Sales by Region (2025-2030) & (K Units)
 Table 20. Global Antifungal Drugs for Skin Sales Market Share by Region (2025-2030)
 Table 21. Global Antifungal Drugs for Skin Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Antifungal Drugs for Skin Revenue Market Share by Region (2019-2024)
 Table 23. Global Antifungal Drugs for Skin Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Antifungal Drugs for Skin Revenue Market Share by Region (2025-2030)
 Table 25. North America Antifungal Drugs for Skin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Antifungal Drugs for Skin Sales by Country (2019-2024) & (K Units)
 Table 27. North America Antifungal Drugs for Skin Sales by Country (2025-2030) & (K Units)
 Table 28. North America Antifungal Drugs for Skin Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Antifungal Drugs for Skin Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Antifungal Drugs for Skin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Antifungal Drugs for Skin Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Antifungal Drugs for Skin Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Antifungal Drugs for Skin Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Antifungal Drugs for Skin Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Antifungal Drugs for Skin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Antifungal Drugs for Skin Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Antifungal Drugs for Skin Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Antifungal Drugs for Skin Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Antifungal Drugs for Skin Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Antifungal Drugs for Skin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Antifungal Drugs for Skin Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Antifungal Drugs for Skin Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Antifungal Drugs for Skin Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Antifungal Drugs for Skin Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Antifungal Drugs for Skin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Antifungal Drugs for Skin Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Antifungal Drugs for Skin Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Antifungal Drugs for Skin Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Antifungal Drugs for Skin Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Antifungal Drugs for Skin Sales (K Units) by Type (2019-2024)
 Table 51. Global Antifungal Drugs for Skin Sales (K Units) by Type (2025-2030)
 Table 52. Global Antifungal Drugs for Skin Sales Market Share by Type (2019-2024)
 Table 53. Global Antifungal Drugs for Skin Sales Market Share by Type (2025-2030)
 Table 54. Global Antifungal Drugs for Skin Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Antifungal Drugs for Skin Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Antifungal Drugs for Skin Revenue Market Share by Type (2019-2024)
 Table 57. Global Antifungal Drugs for Skin Revenue Market Share by Type (2025-2030)
 Table 58. Global Antifungal Drugs for Skin Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Antifungal Drugs for Skin Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Antifungal Drugs for Skin Sales (K Units) by Application (2019-2024)
 Table 61. Global Antifungal Drugs for Skin Sales (K Units) by Application (2025-2030)
 Table 62. Global Antifungal Drugs for Skin Sales Market Share by Application (2019-2024)
 Table 63. Global Antifungal Drugs for Skin Sales Market Share by Application (2025-2030)
 Table 64. Global Antifungal Drugs for Skin Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Antifungal Drugs for Skin Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Antifungal Drugs for Skin Revenue Market Share by Application (2019-2024)
 Table 67. Global Antifungal Drugs for Skin Revenue Market Share by Application (2025-2030)
 Table 68. Global Antifungal Drugs for Skin Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Antifungal Drugs for Skin Price (US$/Unit) by Application (2025-2030)
 Table 70. Harbin Labton Pharmaceutical Co., Ltd. Company Information
 Table 71. Harbin Labton Pharmaceutical Co., Ltd. Description and Business Overview
 Table 72. Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product
 Table 74. Harbin Labton Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 75. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Company Information
 Table 76. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 77. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product
 Table 79. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 80. Livzon Group Livzon Pharmaceutical Factory Company Information
 Table 81. Livzon Group Livzon Pharmaceutical Factory Description and Business Overview
 Table 82. Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Product
 Table 84. Livzon Group Livzon Pharmaceutical Factory Recent Developments/Updates
 Table 85. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Company Information
 Table 86. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Description and Business Overview
 Table 87. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product
 Table 89. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 90. Teyi Pharmaceutical Group Co., Ltd. Company Information
 Table 91. Teyi Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 92. Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product
 Table 94. Teyi Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 95. Lunan Beite Pharmaceutical Co., Ltd. Company Information
 Table 96. Lunan Beite Pharmaceutical Co., Ltd. Description and Business Overview
 Table 97. Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product
 Table 99. Lunan Beite Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 100. Yunnan Longrun Pharmaceutical Co., Ltd. Company Information
 Table 101. Yunnan Longrun Pharmaceutical Co., Ltd. Description and Business Overview
 Table 102. Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product
 Table 104. Yunnan Longrun Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 105. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Company Information
 Table 106. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Description and Business Overview
 Table 107. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product
 Table 109. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 110. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Company Information
 Table 111. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Description and Business Overview
 Table 112. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product
 Table 114. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 115. Shanghai Baolong Pharmaceutical Co., Ltd. Company Information
 Table 116. Shanghai Baolong Pharmaceutical Co., Ltd. Description and Business Overview
 Table 117. Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product
 Table 119. Shanghai Baolong Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 120. Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information
 Table 121. Shandong Fangming Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 122. Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product
 Table 124. Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 125. Nanjing Chengong Pharmaceutical Co., Ltd. Company Information
 Table 126. Nanjing Chengong Pharmaceutical Co., Ltd. Description and Business Overview
 Table 127. Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product
 Table 129. Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 130. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Company Information
 Table 131. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Description and Business Overview
 Table 132. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product
 Table 134. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 135. Zhejiang East Asia Pharmaceutical Co., Ltd. Company Information
 Table 136. Zhejiang East Asia Pharmaceutical Co., Ltd. Description and Business Overview
 Table 137. Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product
 Table 139. Zhejiang East Asia Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 140. Southwest Pharmaceutical Co., Ltd. Company Information
 Table 141. Southwest Pharmaceutical Co., Ltd. Description and Business Overview
 Table 142. Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product
 Table 144. Southwest Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 145. Qilu Pharmaceutical Co., Ltd. Company Information
 Table 146. Qilu Pharmaceutical Co., Ltd. Description and Business Overview
 Table 147. Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product
 Table 149. Qilu Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 150. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Company Information
 Table 151. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Description and Business Overview
 Table 152. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Product
 Table 154. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Recent Developments/Updates
 Table 155. Pfizer Company Information
 Table 156. Pfizer Description and Business Overview
 Table 157. Pfizer Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 158. Pfizer Antifungal Drugs for Skin Product
 Table 159. Pfizer Recent Developments/Updates
 Table 160. Wellona Pharma Company Information
 Table 161. Wellona Pharma Description and Business Overview
 Table 162. Wellona Pharma Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 163. Wellona Pharma Antifungal Drugs for Skin Product
 Table 164. Wellona Pharma Recent Developments/Updates
 Table 165. Aden Healthcare Company Information
 Table 166. Aden Healthcare Description and Business Overview
 Table 167. Aden Healthcare Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 168. Aden Healthcare Antifungal Drugs for Skin Product
 Table 169. Aden Healthcare Recent Developments/Updates
 Table 170. Solisom Healthcare Company Information
 Table 171. Solisom Healthcare Description and Business Overview
 Table 172. Solisom Healthcare Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 173. Solisom Healthcare Antifungal Drugs for Skin Product
 Table 174. Solisom Healthcare Recent Developments/Updates
 Table 175. AS lifesciences Company Information
 Table 176. AS lifesciences Description and Business Overview
 Table 177. AS lifesciences Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 178. AS lifesciences Antifungal Drugs for Skin Product
 Table 179. AS lifesciences Recent Developments/Updates
 Table 180. Amar Healthcare Company Information
 Table 181. Amar Healthcare Description and Business Overview
 Table 182. Amar Healthcare Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 183. Amar Healthcare Antifungal Drugs for Skin Product
 Table 184. Amar Healthcare Recent Developments/Updates
 Table 185. AdvaCare Pharma Company Information
 Table 186. AdvaCare Pharma Description and Business Overview
 Table 187. AdvaCare Pharma Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 188. AdvaCare Pharma Antifungal Drugs for Skin Product
 Table 189. AdvaCare Pharma Recent Developments/Updates
 Table 190. Shree Ganesh Remedies Company Information
 Table 191. Shree Ganesh Remedies Description and Business Overview
 Table 192. Shree Ganesh Remedies Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 193. Shree Ganesh Remedies Antifungal Drugs for Skin Product
 Table 194. Shree Ganesh Remedies Recent Developments/Updates
 Table 195. Dr. Reddy's Laboratories Company Information
 Table 196. Dr. Reddy's Laboratories Description and Business Overview
 Table 197. Dr. Reddy's Laboratories Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 198. Dr. Reddy's Laboratories Antifungal Drugs for Skin Product
 Table 199. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 200. Key Raw Materials Lists
 Table 201. Raw Materials Key Suppliers Lists
 Table 202. Antifungal Drugs for Skin Distributors List
 Table 203. Antifungal Drugs for Skin Customers List
 Table 204. Antifungal Drugs for Skin Market Trends
 Table 205. Antifungal Drugs for Skin Market Drivers
 Table 206. Antifungal Drugs for Skin Market Challenges
 Table 207. Antifungal Drugs for Skin Market Restraints
 Table 208. Research Programs/Design for This Report
 Table 209. Key Data Information from Secondary Sources
 Table 210. Key Data Information from Primary Sources
 Table 211. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antifungal Drugs for Skin
 Figure 2. Global Antifungal Drugs for Skin Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Antifungal Drugs for Skin Market Share by Type: 2023 & 2030
 Figure 4. Ciprofloxacin Product Picture
 Figure 5. Clotrimazole Product Picture
 Figure 6. Miconazole Product Picture
 Figure 7. Amorolfine Product Picture
 Figure 8. Butenafine Product Picture
 Figure 9. Econazole Product Picture
 Figure 10. Ketoconazole Product Picture
 Figure 11. Terbinafine Product Picture
 Figure 12. Other Product Picture
 Figure 13. Global Antifungal Drugs for Skin Market Value by Application (2024-2030) & (US$ Million)
 Figure 14. Global Antifungal Drugs for Skin Market Share by Application: 2023 & 2030
 Figure 15. Hospital
 Figure 16. Clinic
 Figure 17. Other
 Figure 18. Global Antifungal Drugs for Skin Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 19. Global Antifungal Drugs for Skin Market Size (2019-2030) & (US$ Million)
 Figure 20. Global Antifungal Drugs for Skin Sales (2019-2030) & (K Units)
 Figure 21. Global Antifungal Drugs for Skin Average Price (US$/Unit) & (2019-2030)
 Figure 22. Antifungal Drugs for Skin Report Years Considered
 Figure 23. Antifungal Drugs for Skin Sales Share by Manufacturers in 2023
 Figure 24. Global Antifungal Drugs for Skin Revenue Share by Manufacturers in 2023
 Figure 25. Global 5 and 10 Largest Antifungal Drugs for Skin Players: Market Share by Revenue in Antifungal Drugs for Skin in 2023
 Figure 26. Antifungal Drugs for Skin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 27. Global Antifungal Drugs for Skin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 28. North America Antifungal Drugs for Skin Sales Market Share by Country (2019-2030)
 Figure 29. North America Antifungal Drugs for Skin Revenue Market Share by Country (2019-2030)
 Figure 30. United States Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Canada Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Europe Antifungal Drugs for Skin Sales Market Share by Country (2019-2030)
 Figure 33. Europe Antifungal Drugs for Skin Revenue Market Share by Country (2019-2030)
 Figure 34. Germany Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. France Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. U.K. Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Italy Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Russia Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Asia Pacific Antifungal Drugs for Skin Sales Market Share by Region (2019-2030)
 Figure 40. Asia Pacific Antifungal Drugs for Skin Revenue Market Share by Region (2019-2030)
 Figure 41. China Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Japan Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. South Korea Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. India Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Australia Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. China Taiwan Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Southeast Asia Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Latin America Antifungal Drugs for Skin Sales Market Share by Country (2019-2030)
 Figure 49. Mexico Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Brazil Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Argentina Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Colombia Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Middle East and Africa Antifungal Drugs for Skin Sales Market Share by Country (2019-2030)
 Figure 54. Middle East and Africa Antifungal Drugs for Skin Revenue Market Share by Country (2019-2030)
 Figure 55. Turkey Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 56. Saudi Arabia Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 57. UAE Antifungal Drugs for Skin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 58. Global Sales Market Share of Antifungal Drugs for Skin by Type (2019-2030)
 Figure 59. Global Revenue Market Share of Antifungal Drugs for Skin by Type (2019-2030)
 Figure 60. Global Antifungal Drugs for Skin Price (US$/Unit) by Type (2019-2030)
 Figure 61. Global Sales Market Share of Antifungal Drugs for Skin by Application (2019-2030)
 Figure 62. Global Revenue Market Share of Antifungal Drugs for Skin by Application (2019-2030)
 Figure 63. Global Antifungal Drugs for Skin Price (US$/Unit) by Application (2019-2030)
 Figure 64. Antifungal Drugs for Skin Value Chain
 Figure 65. Antifungal Drugs for Skin Production Process
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Fungal Drugs for Treatment of Tinea Market Research Report 2025
Global Anti fungal Drugs Market Insights Forecast to 2030
Global Antifungal and Ringworm Treatment Drugs Market Research Report 2025
Antifungal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Dermatomycosis Treatment Market Research Report 2025
Global Azole Antifungals Market Research Report 2024
Global Ketoconazole API Market Research Report 2024
Global Fungal Foot Drugs Market Insights Forecast to 2030
Global Medical Antifungal Agent Market Research Report 2025
Global Anti Fungal Agents Market Insights Forecast to 2030
OTC Topical Antifungals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Systemic Antifungals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ketoconazole Market Insights Forecast to 2030
Global Fenticonazole Market Research Report 2024
Global Tinea Corporis Drugs Market Research Report 2024
Fluconazole Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Tinea Pedis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fluconazole Preparation Market Research Report 2024
Drugs for Dermatophytosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tinea Corporis Treatment Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions